Status:
RECRUITING
Primary Surgical Prevention of Breast Cancer-related Lymphedema
Lead Sponsor:
Gangnam Severance Hospital
Conditions:
Lymphedema
Mastectomy
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Lymphedema refers to edema caused by insufficient drainage of interstitial fluid through the lymphatic circulation system. It occurs mainly in the upper and lower extremities and causes chronic inflam...
Detailed Description
Patients in the LYMPHA group undergo Axillary reverse mapping before the start of surgery, and after axillary lymph node resection, LYMPHA procedure is performed in which the lymphatic vessels drained...
Eligibility Criteria
Inclusion
- Age over 19 years old
- Patients who are expected to undergo surgery under the diagnosis of breast cancer, and are determined to undergo axillary lymph node dissection before surgery.
Exclusion
- Patients with vascular and lymph-related diseases
- Patients with a history of surgical treatment or trauma to both arms and axillary
- Patients with a history of receiving radiation treatment in both arms, chest, and axilla
- Patients with confirmed systemic metastasis with stage 4 breast cancer
- Pregnant and lactating patients
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04687956
Start Date
February 1 2021
End Date
December 31 2027
Last Update
October 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gangnam Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea, 06273